Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02015806 · ClinicalTrials.gov registry record · NA
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 53,480
- Enrollment target
NCT02015806: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT02015806 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 53,480 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3712% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02015806, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 53,480 participants
- Enrollment target
Study Summary
The aim of this study is to determine whether adherence to oral maintenance medications differs for patients randomized to receive a RxTimerCap, a Take-N-Slide, a standard pillbox, or none of these devices, with the hypothesis that low-touch devices improve adherence over control and that the increase in adherence is agnostic across devices.
Primary Outcome
Optimal adherence to all cardiovascular or non-depression chronic disease medications, defined as a Medication Possession Ratio (MPR) equal to or greater than 80% and assessed using administrative pharmacy claims
Interventions
- BEHAVIORAL RxTimerCap
- BEHAVIORAL Take-N-Slide
- BEHAVIORAL Pillbox
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53,480 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-02 |
| Phase | NA |
What the finished NCT02015806 record still lists
NCT02015806 is an interventional study that assigns participants to a tested intervention. Its 53,480 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3712% higher).
The record links to 0 conditions, and to 3 interventions - of which RxTimerCap is the first listed.
NCT02015806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02015806 about?
NCT02015806 is a clinical study titled "Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices". The aim of this study is to determine whether adherence to oral maintenance medications differs for patients randomized to receive a RxTimerCap, a Take-N-Slide, a standard pillbox, or none of these devices, with the hypothesis that low-touch devices improve adherence over control and that the increa...
What is the current status of trial NCT02015806?
This trial is currently completed. It is a NA study. The enrollment target is 53,480 participants. The study started on 2014-03. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02015806?
The interventions under investigation include: RxTimerCap (BEHAVIORAL), Take-N-Slide (BEHAVIORAL), Pillbox (BEHAVIORAL).
Who is sponsoring clinical trial NCT02015806?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02015806's enrollment target sits among peer trials
53,480 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07224243 · 54,000 participants · NA
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
- NCT05975671 · 52,500 participants · NA
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
- NCT06355934 · 52,121 participants
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia